Press Releases

Jan 11, 2022 8:30am EST

TC BioPharm (Holdings) Limited Names Chris Camarra Executive Vice President, Communications

Oct 13, 2021 8:30am EDT

TC BioPharm Announces Launch of COVID-19 Phase I/II Human Trial

Sep 20, 2021 10:00am EDT

TC BioPharm Announces Dr. Sebastian Wanless as Senior Clinical Director

Aug 12, 2021 1:25pm EDT

TC BioPharm Named as Top 5 Female Powered Companies in United Kingdom

Apr 24, 2019 4:39am EDT

TC BioPharm Initiates Phase I Trial of Allogeneic Gamma Delta T Cell Therapy in Acute Myeloid Leukemia Patients

Mar 29, 2019 5:30am EDT

Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director

Feb 25, 2019 4:00am EST

Immunotherapy Company TC BioPharm Partners with Trinity College Dublin to Develop V Delta 1 γδ T Cell-based Cancer Treatments

Jan 22, 2019 5:55am EST

TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products

rss_feed News RSS

This website stores cookies on your computer. These cookies, which also could include third party cookies, are used (among other purposes) to improve the website and provide more personalized services to you. To find out more about how we use cookies and how to change your settings, see our Privacy Policy.

I Accept